Key points are not available for this paper at this time.
Care more particularly for the individual patient than for the especial features of the disease. William Osler1 One of the most daunting challenges confronting the health care system is how to prevent and manage multiple chronic conditions (MCC) effectively and efficiently. MCC are commonly defined as the co-occurrence of two or more chronic physical or mental health conditions. Some use the term multimorbidity as synonymous with MCC, while others define MCC as including additional factors that contribute to the burden of illness, including disease severity, functional impairments and disabilities, syndromes such as frailty, and sometimes social factors such as homelessness.2 Regardless of definition, MCC are common, costly, and place a high burden on individuals, their caregivers, clinicians, health care teams, and health systems alike. Our fragmented, disease-focused health care system is ill-designed to meet the needs of this growing population. Although prevalence varies with definition,3 MCC is the most common chronic condition seen in clinical practice. One in three American adults, four in five Medicare beneficiaries, and a growing number of children have MCC. People living with MCC account for a disproportionate share of health care utilization and costs, 64% of all clinician visits, 70% of all inpatient stays, 83% of all prescriptions, 71% of all health care spending, and 93% of Medicare spending. Almost half have functional impairments. Nearly all readmissions among Medicare beneficiaries occur among those with MCC.4 The prevalence of MCC will grow with our aging population. The need to improve the care of people living with MCC has been recognized nationally and internationally.5, 6 There is a mismatch between the way care is delivered (disease-specific) and needs (patient-centered) resulting in care that is fragmented and of sub-optimal quality, leading to poor outcomes including avoidable adverse events, hospitalizations, and institutionalization as well as increased costs. People with MCC typically see multiple providers in multiple settings of care and have multiple care transitions. Many experience barriers in access to care or have difficulty navigating the health system to obtain needed services and therefore present with avoidable and costly late-stage diseases. Fragmented care too often leads to problems including drug–drug or drug–disease interactions, therapeutic duplication, polypharmacy, contradictory and confusing recommendations, or a therapeutic regimen that is complicated, burdensome, and challenging to follow. Transforming care for people living with MCC entails organizing health care to take care of people living with illnesses in the context of their lives, respecting their values and preferences, supported by clinical research and guidelines that provide needed evidence and guidance on managing co-existing illnesses and different constellations of diseases. While interventions to improve MCC care have been developed and tested, results have been mixed and when effective modest at best.7 We have learned much about components of effective interventions. However, we do not know which constellation of these components, for which populations, and in which settings of care will result in improved outcomes nor how to widely implement and scale these interventions. The Agency for Healthcare Research and Quality's (AHRQ's) vision for “a sustainable health care system that delivers high-value coordinated, integrated patient-centered care based in primary care, optimizing individual and population health by preventing and effectively managing MCC” remains elusive. The coronavirus disease 2019 (COVID-19) pandemic has underscored the need to increase attention to MCC and the challenges MCC present. People living with MCC are at higher risk for severe disease and mortality from severe acute respiratory syndrome–related coronavirus (SARS-CoV-2) infection.8 In a study from a large integrated health system, 88% of individuals hospitalized with SARS-CoV-2 infection had MCC.9 A growing number of people manifest persistent, debilitating symptoms after infection, postacute sequelae of SARS-CoV-2 infection. These “long haulers” experience consequences across multiple organ systems (e.g., neurologic, cardiac, pulmonary, musculoskeletal), potentially compounded by underlying conditions, with negative impacts on health and quality of life.10 These sequelae may coexist with behavioral and psychosocial consequences of the pandemic (e.g., depression, financial strain, substance abuse, social isolation).11, 12 Thus, the burden of MCC will grow. Racial/ethnic minorities and those who are socioeconomically disadvantaged develop MCC at earlier ages and have more conditions, greater severity of illness, and more functional limitations.13 Women are more likely than men to have MCC across all age groups. At-risk populations are also more likely to encounter access barriers, experience care of lower quality due to well-documented disparities, have multiple social risks, and have less resources to navigate the health system. These factors in the context of MCC increase the risk of poor health outcomes. The prevalence of MCC also varies by geography—one study found MCC prevalence to range from 37.9% in the District of Columbia to 64.4% in West Virginia.8 To be effective, interventions will need to be tailored to local context and resources. Multiple factors, compounded by the COVID-19 pandemic, including rising inequality, social deprivation and isolation, food insecurity, smoking, substance abuse, sedentary lifestyles, and diet, have contributed to the current syndemic of MCC. One single factor alone (e.g., smoking, insufficient physical activity, poverty) can increase the risk of developing multiple conditions such as cardiovascular disease, diabetes, dementia, and depression. While attention has been paid to the sickest individuals with MCC, those with high cost and high needs, limited attention has been paid earlier in the disease continuum. There is opportunity for both primary and secondary prevention among those with multiple risk factors and among those with rising risk who have multiple conditions before they have complex needs, disability, or frailty. Prevention of MCC could be fostered through clinical, public health, and policy interventions. The challenge of MCC is a wicked problem, one that is “complex, unpredictable, open ended, or intractable,”14 as it entails people with complex medical, social, and psychological needs interacting with health systems that are also complex. Wicked problems require innovative solutions that address their complexity. Transforming care for people with MCC is essential for health system sustainability, especially for federal programs including Medicare and Medicaid, that provide care to a disproportionate share of the MCC population. Improving MCC prevention and management is fundamental to supporting the move to value-based payment. A number of concurrent factors provide the foundation for addressing MCC, including a growing body of evidence on the delivery of patient-centered care, advances in implementation science, and increasing recognition of the need for investment in primary care and primary care research.15 Lessons from the disruption and innovation in the way care is delivered generated by the COVID-19 pandemic (e.g., the rapid adoption of telehealth) are providing evidence that can be applied to improve MCC care. These trends along with the growing capability of data and analytics to generate evidence within learning health system make it the opportune time to invest in MCC care. AHRQ developed the Care and Learn Model to bring together two streams of research where there have been considerable advancements over the last decade—patient-centered care delivery and the approaches that support the cycle of evidence synthesis, generation, and implementation within learning health systems.15 Recognizing that the primary function of the health system is to care for people, their families, and caregivers in the context of the communities that they live in and aligned with their goals, values, and preferences, the Care and Learn Model provided a framework for developing this research agenda. We present a research agenda for transforming care for MCC, that builds on AHRQ's portfolio of research in this area, ongoing stakeholder engagement, and informed by an MCC Research Summit held in November 2020.16 Beginning in early 2019, AHRQ launched a series of stakeholder engagement activities along with dialogs with federal partners to develop a research agenda to guide future investments in improving MCC care. This included key informant interviews, open forums, and panel discussions at professional society meetings. Our goal was to elicit comprehensive and diverse perspectives from clinicians, patients, health system leaders, academia, and philanthropies to identify the most pressing challenges in improving MCC care and research needed to address these challenges. Important areas being addressed by others including biomedical research on clinical management or measurement of MCC17 were acknowledged and considered out of scope.17, 18 Three priority areas were identified through this process as follows: patient and family engagement, models of high-value care, and health information technology applications solutions to support people living with MCC and to their improve care. Evidence reviews on each of these issues were commissioned to assess the state of the evidence in the specified domains and to identify knowledge gaps.7, 19, 20 In 2020, we used a systematic process for identifying and prioritizing a research agenda. This process began with an invitation to 40 subject matter experts to review and provide feedback to the evidence review authors, as well as identify key topics, issues, or themes not covered by the evidence reviews. This informed the Virtual Research Summit on Transforming Care for People with Multiple Chronic Conditions, which AHRQ convened in November 2020 and was attended by over 100 researchers, clinicians, patients and caregivers, health IT professionals, health care system and policy experts, and other potential funders of MCC research. Upon registration, participants were asked to provide responses to open-ended questions about care delivery and research gaps and opportunities. Plenary speakers provided high-level overviews of the challenges facing patients and providers and innovative research methods for developing and testing strategies for addressing them. Finally, in a series of sequential and facilitated working sessions, participants identified, consolidated, integrated, and prioritized a group-generated list of key research questions. The research agenda below was developed through this process. Details can be found in the meeting proceedings.16 There is ample opportunity to conduct research to provide the needed evidence to improve the quality and outcomes of care for MCC and the experiences of people living with MCC, their families and caregivers, and the clinicians who provide their care. Evidence reviews revealed a nascent literature in all three priority areas with large gaps that need to be filled to make progress in tackling this wicked problem. Patient-level, practice-level, community-level, and health system–level interventions all have potential, as do multilevel interventions that align these efforts. Progress will require culture change in practice and training for widespread adoption of the paradigms needed to widely implement whole-person care, including the integration of behavioral health and primary care. Current payment models often present a barrier to innovation to redesign care, and evidence is also needed for the effectiveness of different payment models and incentives to support these efforts. Partnerships and policy are needed to address social determinants of health (SDoH) and to assure that these efforts address pervasive health inequities. We not only need to deliver care differently; we need to do research differently to address identified gaps. The research domains below are not mutually exclusive, and effective interventions are likely to be multicomponent and draw from multiple domains. Key questions that emerged from the MCC summit are shown in Table 1. By expanding the “whole-person” approach to embrace medical, behavioral, social, spiritual, and economic dimensions, we need to redesign care for people living with diseases rather than focusing on specific diseases in isolation. This “precision” care needs to be provided in the context of their lives and aligned with their priorities, preferences, and goals.21 This entails not only partnership in patient-centered care planning but also co-design of practices and health systems and co-production of evidence. Strategies are needed to effectively engage people living with MCC and their caregivers and self-management support to help individuals achieve their goals. Clinical practice guidelines and clinical decision support that can inform decision making and minimize harms in managing heterogeneous constellations of conditions are also needed. The recent transformation of primary care toward team-based care in the form of medical homes has been an important structural change, but the potential for this care delivery model has been unrealized and needs renovation. Patients living with MCC would benefit from continuing relationships with a primary care team to help plan and coordinate care. Currently, not all primary care practices have the systems or expertise do this well. Better management of processes of care to address MCC will be required, using collaborative care and disease management models, adapted to the complexities of chronic disease interaction. This will require case identification, goals of care planning, shared decision making, case management, and continuous driving toward achieving optimal patient-centered multidimensional goals. Higher performance of medical homes has been shown to improve preventive services and provider work–life satisfaction,22 and so measurement of medical home performance, will be required to ensure primary care teams have the capacity to deliver the required complex care. While the patient–provider relationship will still require the human need for one-on-one relationship building to engender the trust necessary to potentiate care, the paradigm of care solely within fixed facilities is over. Telehealth and virtual care will remain a significant part of how primary care is delivered, but how to do this optimally and safely without overburdening primary care providers will require rigorous research. IT solutions to support care outside of the office can be designed to specifically address the unique challenges in improving MCC care from patient, caregiver, and clinician perspectives. These technologies will play a crucial role in improving access to care (both primary and specialty), but appropriate boundaries will be required to balance immediacy of care needs with burnout among providers. mHealth applications can allow the collection patient-reported outcomes and provide self-management support. Interoperable shared electronic care plans can not only allow coordination across providers but also enable better communication with the care team and capture preferences, values, goals, and progress toward attaining them along with other patient-generated health data to support care management. We need evidence for the best mix of in-person and virtual care as well as evidence for the effectiveness and safety of IT solutions. A redesigned and better supported medical home is necessary but not sufficient. Improved coordination of primary care and specialty care, seamless transition across settings including acute and postacute care, and access to and coordination with community services are all needed to improve MCC care. There is a need to develop, implement, and evaluate models of care that deliver patient-centered coordinated care to people living with MCC. Health information technology will also be instrumental in allowing the broader health systems to function more seamlessly, allowing for higher quality and safer care transitions, from referral processes to hospital admissions and discharges. Better flow of information would support collaborative and stepped care models to occur in a more integrated manner. Across systems, this will require advances in interoperability and health information exchange capacity. Systemic societal influences that lead to inequitable care will require systemic solutions and the research necessary to optimally program equity into systems of care. Recognition of universal access to primary care as a common good will provide the equal playing ground for the necessary quality improvement processes to raise the health of all, including the most vulnerable and those with the highest illness burden. Without such equal access to care, quality improvement efforts will exacerbate current inequities of care. Additionally, quality improvement activities can narrow, maintain, or widen inequities in quality and outcomes depending on their relative effectiveness and the degree to which they meet the needs of diverse populations. Evidence is needed for interventions tailored specifically to the needs of people living with MCC so that new models of care aimed at improving MCC care do not widen pervasive inequities in this population. Preventing and managing MCC to optimize health outcomes require an increased on health, and is well that living and working conditions or the are the primary of health among both individuals and populations, and the people for this is most the case are those living with MCC. The both increase the risk of developing MCC, may access to care, and provide barriers to optimal management. health and coordination of health interventions and outside of the health system. Evidence is on how social and community services that address can best be integrated with clinical care. primary care, multiple barriers to the individual of clinical care delivery with a population health This with communities and study and social with the care of to improve both individual and population health health may help people living with MCC obtain needed services both and outside the health system. There is evidence that and coordination between public health and primary care can improve outcomes and across that contribute to health (e.g., is also needed. Evidence is needed for models of care that can align and community and human public health, and to MCC care. The of care for MCC an burden on people living with MCC and their caregivers who navigate the health system, share multiple for and are asked to to complex and make the of challenging social of multiple guidelines that to address multimorbidity to complex of burden have been developed to support of interventions aimed at burden. to care delivery have been developed to help minimize including and Evidence is needed to inform decision making, priority and goal and to support care planning to optimize outcomes and minimize burden. The clinicians experience in care to people with MCC are by fragmented care, insufficient coordination across multiple providers and care practice and ill-designed to support MCC care, and electronic health systems increasing the risk of efforts to patient, caregiver, and clinician burden are likely to require and process the evidence needed to care for individuals living with will require new research methods for and complex interventions that address complex patient needs in a range of care people living with MCC, caregivers, and health care teams to and in to account for the in interventions to redesign care do not allow of the to increase effectiveness based on new evidence that the implementation process nor the to the to local context including population needs and resources. there is a growing of research methods that can be to the evidence to improve MCC care. can provide evidence for implementation Multiple implementation rapid cycle and complex on while allowing to the based on outcomes. methods provide into and how the or and in which interventions would result in sustainable and would address health inequities as an of interventions. The of care for MCC will need to be by the health care for managing and addressing complex care, to expertise in of the of high-level communication team-based and patient-centered This has and training for health This will require innovative to research with clinical research in we have not with these will be the necessary of that embrace the of in care teams, and for the of a diverse that more the population they The of MCC is a time that health system sustainability, the future of Medicare and Medicaid, and the health and of the American while is needed. we can and support research to generate the evidence to make progress and as we implement By and innovative models of care to effectively prevent and manage MCC in partnership with people living with MCC, their families, and caregivers, and clinicians, we can the We can the evidence needed for policy to health and and health The health system required to improve MCC care will also lead to more effective and care for The AHRQ research agenda a for future research investment to the We and for their to the AHRQ Multiple Chronic Research Summit 2020 and to the meeting We all the speakers and participants who the AHRQ Multiple Chronic Research Summit 2020 and provided their and The and in this are those of the authors, who are for and do not the of the Agency for Healthcare Research and in this be as an of AHRQ or the of Health and
Bierman et al. (Wed,) studied this question.